FDA Import Refusal SCS-3652925-8/10002/1 — Pfizer Limited
The FDA refused shipment SCS-3652925-8/10002/1 from Pfizer Limited (India) on Sep 16, 2025. The refused product falls under Drugs and Biologics — HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL). Cited charges: 118,3280 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Sep 16, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 62LCA29 HYDROXYCHLOROQUINE SULFATE (ANTI-PROTOZOAL, A-LEISHMANIAL, A-MALARIAL)
- Charges
- 118,3280